Accelerating Medicine Partnership in Alzheimer’s Disease

Accelerating Medicine Partnership in Alzheimer’s Disease

The Accelerating Medicine Partnership for Alzheimer’s Disease (AMP-AD) Knowledge Portal is a premier repository and workspace for multi-omic data generated through the AMP-AD consortia – a public private partnership between academic research groups, industry partners, and non-profit partners. The primary goal of the consortia is to generate and test hypotheses to identify new targets for intervention in the treatment of Alzheimer’s disease. Deposited data includes gene expression, genotype, methylation, CHiP-Seq, DNA methylation, miRNA profiles, and clinical data, among others from human participants as well as animal and cell line model systems. Data is publically released on an aggressive schedule, with data releases occurring every quarter, starting in March 2015.

Learn more about the datasets, collaborators or external research projects by visiting the AMP-AD Knowledge Portal on Synapse.